Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a b in solid cancer von Mudduluru, G, Ceppi, P, Kumarswamy, R, Scagliotti, G V, Papotti, M, Allgayer, H

Volltext

ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine von Ceppi, P, Volante, M, Novello, S, Rapa, I, Danenberg, KD, Danenberg, PV, Cambieri, A, Selvaggi, G, Saviozzi, S, Calogero, R, Papotti, M, Scagliotti, GV

Volltext

PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpoint blockade von Donini, C., Galvagno, F., Rotolo, R., Massa, A., Merlini, A., Scagliotti, G. V., Novello, S., Bironzo, P., Leuci, V., Sangiolo, D.

Volltext

Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer von Shaw, A.T., Varghese, A.M., Solomon, B.J., Costa, D.B., Novello, S., Mino-Kenudson, M., Awad, M.M., Engelman, J.A., Riely, G.J., Monica, V., Yeap, B.Y., Scagliotti, G.V.

Volltext

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant... von Novello, S., Torri, V., Grohe, C., Kurz, S., Serke, M., Wehler, T., Meyer, A., Ladage, D., Geissler, M., Colantonio, I., Cauchi, C., Stoelben, E., Ceribelli, A., Kropf-Sanchen, C., Valmadre, G., Borra, G., Schena, M., Morabito, A., Santo, A., Gregorc, V., Chiari, R., Reck, M., Schmid-Bindert, G., Folprecht, G., Griesinger, F., Follador, A., Pedrazzoli, P., Bearz, A., Caffo, O., Dickgreber, N.J., Irtelli, L., Wiest, G., Monica, V., Porcu, L., Manegold, C., Scagliotti, G.V.

Volltext

Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016 von Marandino, L., La Salvia, A., Sonetto, C., De Luca, E., Pignataro, D., Zichi, C., Di Stefano, R.F., Ghisoni, E., Lombardi, P., Mariniello, A., Reale, M.L., Trevisi, E., Leone, G., Muratori, L., Marcato, M., Bironzo, P., Novello, S., Aglietta, M., Scagliotti, G.V., Perrone, F., Di Maio, M.

Volltext

Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis von Bria, E., Milella, M., Cuppone, F., Novello, S., Ceribelli, A., Vaccaro, V., Sperduti, I., Gelibter, A., Scagliotti, G.V., Cognetti, F., Giannarelli, D.

Volltext

Consensus clustering methodology to improve molecular stratification of non-small cell lung cancer von Manganaro, L., Bianco, S., Bironzo, P., Cipollini, F., Colombi, D., Corà, D., Corti, G., Doronzo, G., Errico, L., Falco, P., Gandolfi, L., Guerrera, F., Monica, V., Novello, S., Papotti, M., Parab, S., Pittaro, A., Primo, L., Righi, L., Sabbatini, G., Sandri, A., Vattakunnel, S., Bussolino, F., Scagliotti, G.V.

Volltext

Addressing the unmet need in lung cancer: The potential of immuno-oncology von Scagliotti, G.V, Bironzo, P, Vansteenkiste, J.F

Volltext

Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer von Novello, S, Scagliotti, G V, Rosell, R, Socinski, M A, Brahmer, J, Atkins, J, Pallares, C, Burgess, R, Tye, L, Selaru, P, Wang, E, Chao, R, Govindan, R

Volltext

The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations von Novello, S, Pinto, C, Torri, V, Porcu, L, Di Maio, M, Tiseo, M, Ceresoli, G, Magnani, C, Silvestri, S, Veltri, A, Papotti, M, Rossi, G, Ricardi, U, Trodella, L, Rea, F, Facciolo, F, Granieri, A, Zagonel, V, Scagliotti, G

Volltext

Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer von Selvaggi, G., Novello, S., Torri, V., Leonardo, E., De Giuli, P., Borasio, P., Mossetti, C., Ardissone, F., Lausi, P., Scagliotti, G. V.

Volltext

Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer von Scagliotti, G.V., Bondarenko, I., Blackhall, F., Barlesi, F., Hsia, T.-C., Jassem, J., Milanowski, J., Popat, S., Sanchez-Torres, J.M., Novello, S., Benner, R.J., Green, S., Molpus, K., Soria, J.-C., Shepherd, F.A.

Volltext

Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project von CRINO, L, SCAGLIOTTI, G. V, SASSI, M, BARNI, S, RAVAIOLI, A, ADAMO, V, PORTALONE, L, CRUCIANI, G, MASOTTI, A, FERRARA, G, GOZZELINO, F, TONATO, M, RICCI, S, DE MARINIS, F, RINALDI, M, GRIDELLI, C, CERIBELLI, A, BIANCO, R, MARANGOLO, M, DI COSTANZO, F

Volltext

Efficacy and safety of everolimus treatment in a hemodialysis patient with metastatic atypical bronchial carcinoid: case report and literature review von Brizzi, M P, La Salvia, A, Tampellini, M, Sonetto, C, Volante, M, Scagliotti, G V

Volltext

Tivantinib added to erlotinib in nonsmall-cell lung cancer: the primary end point was not MET von Scagliotti, G.V., Di Maio, M.

Volltext

Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification von Travis, W D, Brambilla, E, Van Schil, P, Scagliotti, G V, Huber, R M, Sculier, J-P, Vansteenkiste, J, Nicholson, A G

Volltext

Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-tria... von Scagliotti, G.V, Gridelli, C, de Marinis, F, Thomas, M, Dediu, M, Pujol, J.-L, Manegold, C, San Antonio, B, Peterson, P.M, John, W, Chouaki, N, Visseren-Grul, C, Paz-Ares, L.G

Volltext

Prognostic and predictive factors in a randomized phase III trial comparing cisplatin–pemetrexed versus cisplatin–gemcitabine in advanced non-small-cell lung cancer von Syrigos, K.N., Vansteenkiste, J., Parikh, P., von Pawel, J., Manegold, C., Martins, R.G., Simms, L., Sugarman, K.P., Visseren-Grul, C., Scagliotti, G.V.

Volltext

Relationship between efficacy outcomes and weight gain during treatment of advanced, non-squamous, non-small-cell lung cancer patients von Patel, J.D., Pereira, J.R., Chen, J., Liu, J., Guba, S.C., John, W.J., Orlando, M., Scagliotti, G., Bonomi, P.D.

Volltext